Hims & Hers Health, Inc. (HIMS) Institutional Ownership & Insider Trading

506 institutions reported holding Hims & Hers Health, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 61 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

HIMSHims & Hers Health, Inc.Follow HIMS — free

Drug Manufacturers - Specialty & Generic · Healthcare

—

Price chart with a free account

Market cap: 6.5B
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 9 Nov, in 16 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

506 institutions held 67.1% of the shares. Across filers that reported both quarters, shares held changed +4.7%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	506	157	+4.7%	162	123	124	56
Mar 26	432	149	-24.8%	146	64	131	110
Dec 25	474	183	-17.1%	162	50	147	110
Sep 25	499	217	+25.6%	175	84	128	77
Jun 25	494	175	+9.9%	175	122	125	43
Mar 25	417	156	-4.1%	137	100	133	57
Dec 24	380	164	+16.9%	124	98	94	35
Sep 24	299	129	-3.5%	96	57	81	43

Hims & Hers Health, Inc. — questions

Who owns Hims & Hers Health, Inc. stock?: 506 institutions reported Hims & Hers Health, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (12.3%), VANGUARD PORTFOLIO MANAGEMENT LLC (4.5%), VANGUARD CAPITAL MANAGEMENT LLC (4.1%).
Are Hims & Hers Health, Inc. insiders buying or selling?: 61 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Hims & Hers Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.